Select status:
Sort by:
Filter by last updated date

Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and June 2020

Filter by type
Showing 1 to 10 of 1,608
Title Reference number Published Last updated
Larotrectinib for treating NTRK fusion-positive solid tumours Reference number:TA630 TA00630 Published:27 May 2020 20200527 Last updated:27 May 2020 20200527
COVID-19 rapid guideline: children and young people who are immunocompromised Reference number:NG174 NG00174 Published:01 May 2020 20200501 Last updated:21 May 2020 20200521
COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders Reference number:NG167 NG00167 Published:03 April 2020 20200403 Last updated:21 May 2020 20200521
COVID-19 rapid guideline: dialysis service delivery Reference number:NG160 NG00160 Published:20 March 2020 20200320 Last updated:21 May 2020 20200521
COVID-19 rapid guideline: chronic kidney disease Reference number:NG176 NG00176 Published:15 May 2020 20200515 Last updated:15 May 2020 20200515
COVID-19 rapid guideline: interstitial lung disease Reference number:NG177 NG00177 Published:15 May 2020 20200515 Last updated:15 May 2020 20200515
Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer Reference number:TA628 TA00628 Published:13 May 2020 20200513 Last updated:13 May 2020 20200513
Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab Reference number:TA629 TA00629 Published:13 May 2020 20200513 Last updated:13 May 2020 20200513
COVID-19 rapid guideline: acute kidney injury in hospital Reference number:NG175 NG00175 Published:06 May 2020 20200506 Last updated:06 May 2020 20200506
COVID-19 rapid guideline: antibiotics for pneumonia in adults in hospital Reference number:NG173 NG00173 Published:01 May 2020 20200501 Last updated:01 May 2020 20200501